Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVDL vs GSK✓SelectedUSD · GSKNVDL vs GSK performance historyLatest closeAs of-27.51%11/20
Stock and ETF performance explorer

NVDL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-63.4%
GSK return
+6.1%
Excess return
-69.5%
Maximum drawdown
-76.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-27.5%-0.1%-27.4%-27.5%
7D-42.1%-5.3%-36.7%-43.1%
30D-69.9%-3.7%-66.2%-70.1%
3M-69.7%-7.3%-62.4%-69.9%
6M-73.1%-4.2%-68.9%-73.2%
YTD-64.8%+0.9%-65.7%-62.8%
1Y-63.4%+7.3%-70.7%-60.1%
All-63.4%+6.1%-69.5%-60.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling